BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 23721840)

  • 1. [Hepatorenal syndrome: diagnosis, treatment and prevention].
    Egerod Israelsen M; Gluud LL; Bendtsen F; Møller S; Krag AA
    Ugeskr Laeger; 2013 May; 175(22):1562-6. PubMed ID: 23721840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute kidney injury and hepatorenal syndrome in cirrhosis.
    Egerod Israelsen M; Gluud LL; Krag A
    J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.
    Salerno F; Gerbes A; Ginès P; Wong F; Arroyo V
    Gut; 2007 Sep; 56(9):1310-8. PubMed ID: 17389705
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 5.  Hepatorenal syndrome: Current concepts related to diagnosis and management.
    de Mattos ÁZ; de Mattos AA; Méndez-Sánchez N
    Ann Hepatol; 2016; 15(4):474-81. PubMed ID: 27236146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.
    Neri S; Pulvirenti D; Malaguarnera M; Cosimo BM; Bertino G; Ignaccolo L; Siringo S; Castellino P
    Dig Dis Sci; 2008 Mar; 53(3):830-5. PubMed ID: 17939047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatorenal syndrome in patients with cirrhosis.
    Moreau R
    J Gastroenterol Hepatol; 2002 Jul; 17(7):739-47. PubMed ID: 12121502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal impairment in liver diseases].
    Gerbes AL; Gülberg V
    Praxis (Bern 1994); 2006 Oct; 95(40):1535-8. PubMed ID: 17048410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure].
    Lenz K; Buder R; Lohr G; Piringer P; Voglmayr M
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):440-6. PubMed ID: 27241778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of hepatorenal syndrome.
    Carl DE; Sanyal A
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):207-26. PubMed ID: 19305378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
    Ripoll C; Platzer S; Franken P; Aschenbach R; Wienke A; Schuhmacher U; Teichgräber U; Stallmach A; Steighardt J; Zipprich A;
    Trials; 2023 Apr; 24(1):258. PubMed ID: 37020315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatorenal syndrome].
    Baccaro ME; Guevara M
    Gastroenterol Hepatol; 2007 Nov; 30(9):548-54. PubMed ID: 17980134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascites and Hepatorenal Syndrome.
    Adebayo D; Neong SF; Wong F
    Clin Liver Dis; 2019 Nov; 23(4):659-682. PubMed ID: 31563217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
    Boyer TD; Sanyal AJ; Wong F; Frederick RT; Lake JR; O'Leary JG; Ganger D; Jamil K; Pappas SC;
    Gastroenterology; 2016 Jun; 150(7):1579-1589.e2. PubMed ID: 26896734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The therapy of the hepatorenal syndrome in liver cirrhosis].
    Biecker E; Brensing KA; Perz J; Woitas R; Sauerbruch T
    Dtsch Med Wochenschr; 1999 Sep; 124(36):1039-42. PubMed ID: 10506842
    [No Abstract]   [Full Text] [Related]  

  • 16. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.
    European Association for the Study of the Liver
    J Hepatol; 2010 Sep; 53(3):397-417. PubMed ID: 20633946
    [No Abstract]   [Full Text] [Related]  

  • 17. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F; Pantea L; Sniderman K
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in our understanding of hepatorenal syndrome.
    Wong F
    Nat Rev Gastroenterol Hepatol; 2012 May; 9(7):382-91. PubMed ID: 22614754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatorenal syndrome.
    Guevara M; Rodés J
    Int J Biochem Cell Biol; 2005 Jan; 37(1):22-6. PubMed ID: 15381144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and therapy of ascites in liver cirrhosis.
    Biecker E
    World J Gastroenterol; 2011 Mar; 17(10):1237-48. PubMed ID: 21455322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.